Advertisement

DFV Doxivet

Main information

  • Trade name:
  • DFV Doxivet 500 mg/g, Powder for Use in Drinking Water for Pigs and Chickens
  • Available from:
  • Divasa - Farmavic S.A
  • Pharmaceutical form:
  • Powder for use in drinking water
  • Prescription type:
  • POM-V - Prescription Only Medicine – Veterinarian
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug
Advertisement

Documents

Localization

  • Available in:
  • DFV Doxivet 500 mg/g, Powder for Use in Drinking Water for Pigs and Chickens
    United Kingdom
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • Chickens, Pigs
  • Therapeutic area:
  • Antimicrobial

Other information

Advertisement

Status

  • Source:
  • VMD - Veterinary Medicines Directorate
  • Authorization status:
  • Authorized
  • Authorization number:
  • 33229/4002
  • Authorization date:
  • 12-08-2011
  • Last update:
  • 21-12-2016

Summary of Product characteristics

Advertisement

Revised: July 2016

AN: 01379/2015

SUMMARY OF PRODUCT CHARACTERISTICS

1. NAME OF THE VETERINARY MEDICINAL PRODUCT

DFV DOXIVET 500 mg/g, powder for use in drinking water for pigs and chickens.

CZ: DFV DOXYCYCLINE 500 mg/g, oral powder for use in drinking water for pigs

and chickens.

IT: Doxycycline 500 mg/g DFV, oral powder for use in drinking water for pigs and

chickens

DK: Doxycycline Divasa-Farmavic Vet.

SE: Doxycycline Divasa-Farmavic 500 mg/g pulver för användning I dricksvatten

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Composition for 1 g:

Active substance:

Doxycycline hyclate 500 mg

(equivalent to 433 mg doxycycline base)

Excipients:

For a full list of excipients, see section 6.1.

3. PHARMACEUTICAL FORM

Powder for use in drinking water

Yellow to pale yellow powder.

4. CLINICAL PARTICULARS

4.1 Target species

Pigs and chickens (broiler, pullet, breeder).

4.2 Indications for use, specifying the target species

Pigs: For the treatment of the clinical signs associated with porcine respiratory

disease caused by Actinobacillus pleuropneumoniae, Pasteurella multocida, and

Mycoplasma hyopneumoniae susceptible to doxycycline.

Chickens: Where clinical disease is present in the flock, to reduce mortality, morbidity,

and clinical signs and to reduce lesions due to Pasteurellosis caused by Pasteurella

multocida or to reduce morbidity and lesions in respiratory infections caused by

Ornithobacterium rhinotracheale (ORT).

4.3 Contraindications

Page 1 of 6

Revised: July 2016

AN: 01379/2015

Do not use in case of hypersensitivity to the active substance or to any of the

excipients.

Do not use in animals with an impaired liver function.

4.4 Special warnings for each target species

None.

4.5 Special precautions for use

Special precautions for use in animals

Due to likely variability (time, geographical) in susceptibility of bacteria for

doxycycline, especially susceptibility of A. pleuropneumoniae and O. rhinotracheale

may differ from country to country and even farm to farm, bacteriological sampling

and susceptibility testing are recommended.

Use of the product should be based on culture and sensitivity of micro-organisms

from diseased cases on farm. If this is not possible, therapy should be based on local

(regional, farm level) epidemiological information about susceptibility of the target

bacteria.

As eradication of the target pathogens may not be achieved, medication should

therefore be combined with good management practices, e.g. good hygiene, proper

ventilation, no overstocking.

Special precautions to be taken by the person administering the veterinary

medicinal product to animals

If you know you are allergic to the tetracycline class of antibiotics, special care should

be taken when handling this product or the medicated solution.

During preparation and administration of the medicated drinking water, skin contact

with the product and inhalation of dust particles should be avoided. Wear

impermeable gloves (e.g. rubber or latex) and an appropriate dust mask (e.g.

disposable half-mask respirator conforming to European Standard EN149) when

applying the product.

In the event of eye or skin contact, rinse the affected area with large amounts of

clean water and if irritation occurs, seek medical attention. Wash hands and

contaminated skin immediately after handling the product.

If you develop symptoms following exposure such as skin rash, you should seek

medical advice and show this warning to the physician. Swelling of the face, lips or

eyes, or difficulty with breathing are more serious symptoms and require urgent

medical attention.

Do not smoke, eat or drink while handling the product.

Take measures to avoid producing dust when incorporating the product into water.

Avoid direct contact with skin and eyes when handling the product to prevent

sensitisation and contact dermatitis.

4.6 Adverse reactions (frequency and seriousness)

Tetracyclines may - in very rare cases - induce photosensitivity and allergic reactions.

If suspected adverse reactions occur, treatment should be discontinued. Inform your

veterinary surgeon if adverse reactions occur that are not stated.

4.7 Use during pregnancy, lactation or lay

Doxycycline has a low affinity for forming complexes with calcium and studies have

demonstrated that doxycycline scarcely affects skeleton formation. No negative

Page 2 of 6

Revised: July 2016

AN: 01379/2015

effects were observed in poultry after the administration of therapeutic doses of

doxycycline.

In the absence of specific studies the use of the product is not recommended during

pregnancy or lactation.

4.8 Interaction with other medicinal products and other forms of interaction

Do not combine with antibiotics that are bactericidal e.g. penicillins or cephalosporins.

Absorption of doxycycline can be decreased in the presence of high quantities of

calcium, iron, magnesium or aluminium in the diet. Do not administered together with

antacids, kaolin and iron preparations.

It is advised that the interval between the administration of other products containing

polyvalent cations should be 1-2 hours because they limit the absorption of

tetracyclines.

Doxycycline increases the action of anticoagulants.

The solubility of the product is pH dependent and will precipitate if mixed in alkaline

solution.

Do not store the drinking water in metallic containers.

4.9 Amounts to be administered and administration route

Administration orally with the drinking water.

The recommended dose in pigs is:

12.5 mg doxycycline hyclate (25 mg product) per kg body weight per day for 4

consecutive days. If no improvement in clinical signs is seen within this time, the

diagnosis should be reviewed and treatment changed. In case of severe infections

the medication period may be prolonged for a maximum of 8 consecutive days as

determined by the attending veterinary surgeon.

The recommended dose in chickens is:

10 mg doxycycline hyclate (20 mg product) per kg body weight per day for 3-4

consecutive days in case of infections caused by P. multocida and 20 mg doxycycline

hyclate (40 mg product) per kg body weight per day for 3-4 consecutive days in case

of infections caused by O. rhinotracheale.

Based on the dose to be used, and the number and weight of the animals to be

treated, the exact daily amount of product can be calculated. The following formula

can be used to calculate the concentration of the product in drinking water:

..... mg product/ kg

body

weight / day x mean body weight (kg)

of animals to be treated = .... mg product per l

drinking water

mean daily water consumption (l) per animal

To ensure a correct dosage body weight should be determined as accurately as

possible. The uptake of medicated drinking water depends on the clinical condition of

the animals. In order to obtain the correct dosage the concentration of doxycycline

has to be adjusted accordingly. The use of suitably calibrated weighing equipment is

recommended if part packs are used. The daily amount is to be added to the drinking

water such that all medication will be consumed in 24 hours. Medicated drinking

water should be refreshed or replaced every 24 hours. It is recommended to prepare

a concentrated pre-solution - approximately 100 grams product per litre drinking

water - and to dilute this further to therapeutic concentrations if required. Alternatively,

Page 3 of 6

Revised: July 2016

AN: 01379/2015

the concentrated solution can be used in a proportional water medicator. Solubility of

the product is pH dependent and it may precipitate if it is mixed in hard alkaline

drinking water. Use at minimum concentrations of 200 mg powder per litre drinking

water in areas with hard alkaline drinking water (hardness above 10.2 °d and pH

more than 8.1). During the treatment period animals should not have access to other

water sources than the medicated water.

4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary

Overdoses up to 1.6 times the label recommended dose resulted in no clinical signs

that could be attributed to treatment. Poultry tolerate double overdoses of

doxycycline (40 mg/kg body weight) without any clinical effect.

4.11 Withdrawal periods

Pigs:

- Meat and offal: 4 days

Chickens:

- Meat and offal: 3 days, following a dose rate of 10 mg/kg body weight for 4 days.

- Meat and offal: 12 days, following a dose rate of 20 mg/kg body weight for 4 days.

- Eggs: Not authorised for use in laying birds producing eggs for human consumption.

Do not use within 4 weeks of onset of the laying period

5. PHARMACOLOGICAL PROPERTIES

Pharmacotherapeutic group: Antiinfectives for systemic use, antibacterials for

systemic use, tetracycline, doxycycline

ATCvet code: QJ01AA02

5.1 Pharmacodynamic properties

Doxycycline belongs to the group of the tetracycline antibiotics. These antibiotics

have a broad spectrum of antimicrobial activity, sharing the same basic structure of

polycyclic naphthacenecarboxamide.

Doxycycline is primarily a bacteriostatic drug. It exerts its action by inhibiting the

protein synthesis of the bacterial cell. Inhibition of bacterial protein synthesis results

in disturbance of all functions necessary for the life of bacteria. Especially cell-division

and the formation of the cell wall are impaired.

Doxycycline is a broad-spectrum antibiotic, active against a large number of Gram-

positive and Gram-negative, aerobe and anaerobe micro-organisms, Mycoplasmata,

Chlamydiae and Rickettsia.

For Ornithobacterium rhinotracheale results demonstrate a great variation from high

to low susceptibility, depending on the geographical region where isolates came from.

In pig pathogens resistance against doxycycline may also vary; especially

susceptibility figures of A. pleuropneumoniae may differ from country to country and

even farm to farm.

Four resistance mechanisms acquired by microorganisms against tetracyclines in

general have been reported: Decreased accumulation of tetracyclines (decreased

permeability of the bacterial cell wall and active efflux), protein protection of the

bacterial ribosome, enzymatic inactivation of the antibiotic and rRNA mutations

(preventing the tetracycline binding to ribosome). Tetracycline resistance is usually

acquired by means of plasmids or other mobile elements (e.g. conjugative

transposones). Cross resistance between tetracyclines has also been described. Due

to the greater liposolubility and greater facility to pass through cell membranes (in

Page 4 of 6

Revised: July 2016

AN: 01379/2015

comparison to tetracycline), doxycycline retains a certain degree of efficacy against

microorganisms with acquired resistance to tetracyclines.

5.2 Pharmacokinetic properties

Doxycycline is absorbed in the stomach and the first part of the duodenum.

Compared to the older tetracyclines the absorption of doxycycline is less affected by

the presence of bivalent cations in food. Bioavailability in non-fasted pigs is

approximately 21%.

Following oral administration at a dose of 12.8 mg/kg body weight, steady state

concentrations during medication range between a C

min of 0.40 μg/ml in the early

morning to a C

max of 0.87 μg/ml in the late afternoon in pigs.

Following administration of doxycycline hyclate at an actual dose of 21 mg/kg body

weight to chickens mean plasma concentrations above 1 μg/ml were reached within 6

hours and lasted for 6 hours after cessation of medication. From 24 h up to 96 h after

start of treatment the doxycycline plasma concentrations exceeded 2 μg/ml.

Following administration of doxycycline hyclate at an actual dose of 10 mg/kg body

weight steady state plasma concentrations ranged from 0.75 to 0.93 μg/g between

12 and 96 hours after start of medication.

Because doxycycline is highly lipid soluble, it has a good tissue penetration.

Respiratory tract tissue: plasma ratios of 1.3 (healthy lungs), 1.9 (pneumonic lungs)

and 2.3 (nasal mucosa) have been reported for doxycycline. Plasma protein binding

is high (over 90%).

Doxycycline is scarcely metabolised. Doxycycline is primarily excreted with the

faeces.

6. PHARMACEUTICAL PARTICULARS

6.1 List of excipients

Silica colloidal anhydrous

Citric acid anhydrous

6.2 Incompatibilities

Solubility of doxycycline is pH dependent. Precipitation will occur in an alkaline

solution. In the absence of compatibility studies, this product must not be mixed with

other veterinary medicinal products.

6.3 Shelf life

Shelf-life of the veterinary medicinal product as packaged for sale: 2 years.

Shelf-life after first opening the immediate packaging: 12 months.

Shelf-life after dilution or reconstitution according to directions: 24 hours after dilution in

drinking water.

6.4 Special precautions for storage

This veterinary medicinal product does not require any special storage conditions.

6.5 Nature and composition of immediate packaging

Page 5 of 6

Revised: July 2016

AN: 01379/2015

Nature of container:

Bag formed of polyester/aluminium/polyethylene laminate.

Package sizes:

Carton box 10 x 100 g

Carton box 50 x 100 g

Carton box 250 x 100 g

Bag 1 kg

Bag 2.5 kg

Not all pack sizes may be marketed.

6.6 Special precautions for the disposal of unused veterinary medicinal

product or waste materials derived from the use of such product

Any unused veterinary medicinal product or waste materials derived from such

veterinary medicinal product should be disposed of in accordance with local

requirements.

7. MARKETING AUTHORISATION HOLDER

DIVASA-FARMAVIC S.A.

Ctra. Sant Hipòlit, km 71

08503 Gurb-Vic

Barcelona (Spain)

8. MARKETING AUTHORISATION NUMBER

Vm 33229/4002

9. DATE OF FIRST AUTHORISATION

12 August 2011

10. DATE OF REVISION OF THE TEXT

July 2016

19 July 2016

Page 6 of 6

There are no safety alerts related to this product.

17-1-2017

BIRD BIOTIC (Doxycycline Hyclate) Powder, For Solution [Thomas Labs, LLC]

BIRD BIOTIC (Doxycycline Hyclate) Powder, For Solution [Thomas Labs, LLC]

Updated Date: Jan 17, 2017 EST

US - DailyMed

17-1-2017

FISH DOXY (Doxycycline Hyclate) Powder [Thomas Labs, LLC]

FISH DOXY (Doxycycline Hyclate) Powder [Thomas Labs, LLC]

Updated Date: Jan 17, 2017 EST

US - DailyMed

13-1-2017

DOXYCYCLINE HYCLATE Capsule DOXYCYCLINE HYCLATE Tablet [Actavis Pharma, Inc.]

DOXYCYCLINE HYCLATE Capsule DOXYCYCLINE HYCLATE Tablet [Actavis Pharma, Inc.]

Updated Date: Jan 13, 2017 EST

US - DailyMed

20-12-2016

DOXYCYCLINE HYCLATE Tablet [STI Pharma LLC]

DOXYCYCLINE HYCLATE Tablet [STI Pharma LLC]

Updated Date: Dec 20, 2016 EST

US - DailyMed

19-12-2016

DOXYCYCLINE HYCLATE Tablet, Film Coated [NuCare Pharmaceuticals, Inc.]

DOXYCYCLINE HYCLATE Tablet, Film Coated [NuCare Pharmaceuticals, Inc.]

Updated Date: Dec 19, 2016 EST

US - DailyMed

16-12-2016

DOXYCYCLINE (Doxycycline Hyclate) Tablet, Coated [A-S Medication Solutions]

DOXYCYCLINE (Doxycycline Hyclate) Tablet, Coated [A-S Medication Solutions]

Updated Date: Dec 16, 2016 EST

US - DailyMed

12-12-2016

ATRIDOX (Doxycycline Hyclate) Kit [Den-Mat Holdings, LLC]

ATRIDOX (Doxycycline Hyclate) Kit [Den-Mat Holdings, LLC]

Updated Date: Dec 12, 2016 EST

US - DailyMed

12-12-2016

DOXYCYCLINE (Doxycycline Hyclate) Tablet, Coated [West-Ward Pharmaceuticals Corp]

DOXYCYCLINE (Doxycycline Hyclate) Tablet, Coated [West-Ward Pharmaceuticals Corp]

Updated Date: Dec 12, 2016 EST

US - DailyMed

7-12-2016

DOXYCYLINE HYCLATE (Doxycycline Hyclate) Powder [Attix Pharmaceuticals Inc]

DOXYCYLINE HYCLATE (Doxycycline Hyclate) Powder [Attix Pharmaceuticals Inc]

Updated Date: Dec 7, 2016 EST

US - DailyMed

28-11-2016

DOXYCYCLINE HYCLATE Tablet, Delayed Release [Solco Healthcare US LLC]

DOXYCYCLINE HYCLATE Tablet, Delayed Release [Solco Healthcare US LLC]

Updated Date: Nov 28, 2016 EST

US - DailyMed

18-11-2016

DOXYCYCLINE HYCLATE Capsule [REMEDYREPACK INC.]

DOXYCYCLINE HYCLATE Capsule [REMEDYREPACK INC.]

Updated Date: Nov 18, 2016 EST

US - DailyMed

8-11-2016

DOXYCYCLINE HYCLATE Capsule [DIRECT RX]

DOXYCYCLINE HYCLATE Capsule [DIRECT RX]

Updated Date: Nov 8, 2016 EST

US - DailyMed

1-11-2016

DOXYCYCLINE HYCLATE Capsule [PD-Rx Pharmaceuticals, Inc.]

DOXYCYCLINE HYCLATE Capsule [PD-Rx Pharmaceuticals, Inc.]

Updated Date: Nov 1, 2016 EST

US - DailyMed

31-10-2016

DOXYCYCLINE HYCLATE Capsule [Unit Dose Services]

DOXYCYCLINE HYCLATE Capsule [Unit Dose Services]

Updated Date: Oct 31, 2016 EST

US - DailyMed

28-10-2016

DOXYCYCLINE HYCLATE Tablet, Film Coated [Sun Pharmaceutical Industries, Inc.]

DOXYCYCLINE HYCLATE Tablet, Film Coated [Sun Pharmaceutical Industries, Inc.]

Updated Date: Oct 28, 2016 EST

US - DailyMed

27-10-2016

DOXYCYCLINE HYCLATE Capsule, Gelatin Coated [Unit Dose Services]

DOXYCYCLINE HYCLATE Capsule, Gelatin Coated [Unit Dose Services]

Updated Date: Oct 27, 2016 EST

US - DailyMed

27-10-2016

DOXYCYCLINE HYCLATE Tablet [A-S Medication Solutions]

DOXYCYCLINE HYCLATE Tablet [A-S Medication Solutions]

Updated Date: Oct 27, 2016 EST

US - DailyMed

26-10-2016

DOXYCYCLINE HYCLATE Capsule [A-S Medication Solutions]

DOXYCYCLINE HYCLATE Capsule [A-S Medication Solutions]

Updated Date: Oct 26, 2016 EST

US - DailyMed

24-10-2016

DOXYCYCLINE HYCLATE Tablet [Preferred Pharmaceuticals, Inc.]

DOXYCYCLINE HYCLATE Tablet [Preferred Pharmaceuticals, Inc.]

Updated Date: Oct 24, 2016 EST

US - DailyMed

24-10-2016

DOXYCYCLINE HYCLATE Capsule, Gelatin Coated [Preferred Pharmaceuticals, Inc.]

DOXYCYCLINE HYCLATE Capsule, Gelatin Coated [Preferred Pharmaceuticals, Inc.]

Updated Date: Oct 24, 2016 EST

US - DailyMed

5-10-2016

DOXYCYCLINE HYCLATE Tablet, Film Coated [Epic Pharma, LLC]

DOXYCYCLINE HYCLATE Tablet, Film Coated [Epic Pharma, LLC]

Updated Date: Oct 5, 2016 EST

US - DailyMed

5-10-2016

DOXYCYCLINE HYCLATE Capsule [NuCare Pharmaceuticals, Inc.]

DOXYCYCLINE HYCLATE Capsule [NuCare Pharmaceuticals, Inc.]

Updated Date: Oct 5, 2016 EST

US - DailyMed

20-9-2016

DOXYCYCLINE HYCLATE Tablet, Film Coated [Lannett Company, Inc.]

DOXYCYCLINE HYCLATE Tablet, Film Coated [Lannett Company, Inc.]

Updated Date: Sep 20, 2016 EST

US - DailyMed

7-9-2016

DOXYCYCLINE (Doxycycline Hyclate) Tablet, Coated [PD-Rx Pharmaceuticals, Inc.]

DOXYCYCLINE (Doxycycline Hyclate) Tablet, Coated [PD-Rx Pharmaceuticals, Inc.]

Updated Date: Sep 7, 2016 EST

US - DailyMed

31-8-2016

DOXYCYCLINE HYCLATE Tablet, Film Coated [Chartwell RX LLC]

DOXYCYCLINE HYCLATE Tablet, Film Coated [Chartwell RX LLC]

Updated Date: Aug 31, 2016 EST

US - DailyMed

31-8-2016

DOXYCYCLINE HYCLATE Capsule [Chartwell RX LLC]

DOXYCYCLINE HYCLATE Capsule [Chartwell RX LLC]

Updated Date: Aug 31, 2016 EST

US - DailyMed

30-8-2016

DOXYCYCLINE HYCLATE Tablet, Film Coated [Clinical Solutions Wholesale, LLC]

DOXYCYCLINE HYCLATE Tablet, Film Coated [Clinical Solutions Wholesale, LLC]

Updated Date: Aug 30, 2016 EST

US - DailyMed

29-8-2016

TARGADOX (Doxycycline Hyclate) Tablet [Journey Medical Corporation]

TARGADOX (Doxycycline Hyclate) Tablet [Journey Medical Corporation]

Updated Date: Aug 29, 2016 EST

US - DailyMed

25-8-2016

DOXYCYCLINE HYCLATE Tablet, Film Coated [Cambridge Therapeutics Technologies, LLC]

DOXYCYCLINE HYCLATE Tablet, Film Coated [Cambridge Therapeutics Technologies, LLC]

Updated Date: Aug 25, 2016 EST

US - DailyMed

23-8-2016

DOXYCYCLINE HYCLATE Capsule [Preferred Pharmaceuticals Inc.]

DOXYCYCLINE HYCLATE Capsule [Preferred Pharmaceuticals Inc.]

Updated Date: Aug 23, 2016 EST

US - DailyMed

11-8-2016

DOXYCYCLINE HYCLATE Capsule [Harris Pharmaceutical, Inc]

DOXYCYCLINE HYCLATE Capsule [Harris Pharmaceutical, Inc]

Updated Date: Aug 11, 2016 EST

US - DailyMed

11-8-2016

DOXYCYCLINE HYCLATE Tablet, Film Coated [Harris Pharmaceutical, Inc]

DOXYCYCLINE HYCLATE Tablet, Film Coated [Harris Pharmaceutical, Inc]

Updated Date: Aug 11, 2016 EST

US - DailyMed

11-8-2016

DOXYCYCLINE HYCLATE Capsule [Proficient Rx LP]

DOXYCYCLINE HYCLATE Capsule [Proficient Rx LP]

Updated Date: Aug 11, 2016 EST

US - DailyMed

10-8-2016

DOXYCYCLINE HYCLATE Tablet [Liberty Pharmaceuticals, Inc.]

DOXYCYCLINE HYCLATE Tablet [Liberty Pharmaceuticals, Inc.]

Updated Date: Aug 10, 2016 EST

US - DailyMed

18-7-2016

DORYX MPC (Doxycycline Hyclate) Tablet, Delayed Release [Mayne Pharma]

DORYX MPC (Doxycycline Hyclate) Tablet, Delayed Release [Mayne Pharma]

Updated Date: Jul 18, 2016 EST

US - DailyMed

8-7-2016

DOXYCYCLINE HYCLATE Tablet [PuraCap Laboratories LLC]

DOXYCYCLINE HYCLATE Tablet [PuraCap Laboratories LLC]

Updated Date: Jul 8, 2016 EST

US - DailyMed

29-6-2016

DOXYCYCLINE HYCLATE Capsule DOXYCYCLINE HYCLATE Tablet, Film Coated [Alvogen, Inc.]

DOXYCYCLINE HYCLATE Capsule DOXYCYCLINE HYCLATE Tablet, Film Coated [Alvogen, Inc.]

Updated Date: Jun 29, 2016 EST

US - DailyMed

28-6-2016

DOXYCYCLINE HYCLATE (Doxycycline) Capsule [Amneal Pharmaceuticals LLC]

DOXYCYCLINE HYCLATE (Doxycycline) Capsule [Amneal Pharmaceuticals LLC]

Updated Date: Jun 28, 2016 EST

US - DailyMed

6-6-2016

DOXYCYCLINE HYCLATE Tablet, Delayed Release [Mayne Pharma International Pty Ltd]

DOXYCYCLINE HYCLATE Tablet, Delayed Release [Mayne Pharma International Pty Ltd]

Updated Date: Jun 6, 2016 EST

US - DailyMed

1-6-2016

DOXYCYCLINE (Doxycycline Hyclate) Tablet, Coated [Major Pharmaceuticals]

DOXYCYCLINE (Doxycycline Hyclate) Tablet, Coated [Major Pharmaceuticals]

Updated Date: Jun 1, 2016 EST

US - DailyMed

24-5-2016

DOXYCYCLINE HYCLATE Tablet, Delayed Release [Mylan Pharmaceuticals Inc.]

DOXYCYCLINE HYCLATE Tablet, Delayed Release [Mylan Pharmaceuticals Inc.]

Updated Date: May 24, 2016 EST

US - DailyMed

17-5-2016

DOXIROBE GEL (Doxycycline Hyclate) Gel [Zoetis Inc.]

DOXIROBE GEL (Doxycycline Hyclate) Gel [Zoetis Inc.]

Updated Date: May 17, 2016 EST

US - DailyMed

12-5-2016

DOXYCYCLINE (Doxycycline Hyclate) Capsule [Greenstone LLC]

DOXYCYCLINE (Doxycycline Hyclate) Capsule [Greenstone LLC]

Updated Date: May 12, 2016 EST

US - DailyMed

18-4-2016

DOXYCYCLINE HYCLATE Capsule DOXYCYCLINE HYCLATE Tablet [Cardinal Health]

DOXYCYCLINE HYCLATE Capsule DOXYCYCLINE HYCLATE Tablet [Cardinal Health]

Updated Date: Apr 18, 2016 EST

US - DailyMed

15-4-2016

DOXYCYCLINE (Doxycycline Hyclate) Tablet, Coated [Cardinal Health]

DOXYCYCLINE (Doxycycline Hyclate) Tablet, Coated [Cardinal Health]

Updated Date: Apr 15, 2016 EST

US - DailyMed

6-4-2016

DOXYCYCLINE HYCLATE Tablet, Film Coated [A-S Medication Solutions]

DOXYCYCLINE HYCLATE Tablet, Film Coated [A-S Medication Solutions]

Updated Date: Apr 6, 2016 EST

US - DailyMed

18-3-2016

DOXYCYCLINE HYCLATE Tablet [Putney, Inc.]

DOXYCYCLINE HYCLATE Tablet [Putney, Inc.]

Updated Date: Mar 18, 2016 EST

US - DailyMed

11-3-2016

DOXYCYCLINE HYCLATE Tablet, Film Coated [CorePharma, LLC]

DOXYCYCLINE HYCLATE Tablet, Film Coated [CorePharma, LLC]

Updated Date: Mar 11, 2016 EST

US - DailyMed

16-2-2016

DOXYCYCLINE HYCLATE Capsule, Gelatin Coated [West-Ward Pharmaceuticals Corp]

DOXYCYCLINE HYCLATE Capsule, Gelatin Coated [West-Ward Pharmaceuticals Corp]

Updated Date: Feb 16, 2016 EST

US - DailyMed

5-2-2016

DOXYCYCLINE HYCLATE Tablet [Avera McKennan Hospital]

DOXYCYCLINE HYCLATE Tablet [Avera McKennan Hospital]

Updated Date: Feb 5, 2016 EST

US - DailyMed

1-2-2016

DOXYCYCLINE HYCLATE Tablet, Delayed Release [Mayne Pharma Inc.]

DOXYCYCLINE HYCLATE Tablet, Delayed Release [Mayne Pharma Inc.]

Updated Date: Feb 1, 2016 EST

US - DailyMed

Advertisement